{"id":"W2949665037","doi":"10.1016/s2213-8587(19)30180-9","title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":675,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Janssen Research and Development; St. Jude Medical; Duke Clinical Research Institute; Eisai; Daiichi-Sankyo; Deutsche Forschungsgemeinschaft; Regado Biosciences; Medicines Company; Bristol-Myers Squibb; Cleveland Clinic; Society for Academic Continuing Medical Education; Biotronik; AstraZeneca; Amarin Corporation; Boston VA Research Institute; Boston Scientific Corporation; MyoKardia; Bayer; Gilead Sciences; Takeda Pharmaceutical Company; American College of Cardiology Foundation; Novartis; Mayo Clinic; Merck; GlaxoSmithKline; Icahn School of Medicine at Mount Sinai; Eli Lilly and Company; Boehringer Ingelheim; Amgen; MedImmune; Sanofi; Abbott Laboratories","keywords":"Medicine; Dapagliflozin; Renal function; Type 2 diabetes; Internal medicine; Kidney disease; TIMI; Dialysis; Diabetes mellitus; Creatinine; Albuminuria; Urology; Endocrinology; Myocardial infarction; Percutaneous coronary intervention","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002414805,0.0002148694,0.0008994177,0.0001571879,0.0000368757,0.00001031233,0.0002127208,0.00004179082,0.00003839716],"category_scores_gemma":[0.0002321439,0.0001055148,0.00007568079,0.0003231706,0.0001367916,0.00004869638,0.0001014162,0.0001289588,0.000005960027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003639258,"about_ca_system_score_gemma":0.00006756886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009967247,"about_ca_topic_score_gemma":0.000009599512,"domain_scores_codex":[0.9982929,0.0002631748,0.0003211693,0.0003228437,0.0002731766,0.0005267223],"domain_scores_gemma":[0.9984193,0.0006037042,0.0002095162,0.0005769753,0.00005842707,0.0001320602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03553611,0.0008377712,0.9499608,0.0001457772,0.001766859,0.000003599044,0.0002504359,0.00002307997,0.0002219425,0.00004901844,0.00008442142,0.01112023],"study_design_scores_gemma":[0.1341856,0.002168505,0.8542124,0.0002671079,0.001861144,7.308838e-9,0.00001967794,0.0001629958,0.006378829,0.00004100093,0.000586167,0.0001165497],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963247,0.0004478884,7.291971e-7,0.0004233532,0.0001173794,0.002533681,0.00001769736,0.00002320032,0.0001113837],"genre_scores_gemma":[0.9984289,0.0000428433,0.0001964179,0.0007797834,0.00004793255,0.0001868986,0.000265391,0.00001754248,0.00003427665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09864948,"threshold_uncertainty_score":0.4302768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00957636408848811,"score_gpt":0.2479161079042929,"score_spread":0.2383397438158048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}